LiverRight, a national virtual liver clinic, and Aegle Medical Solutions, LLC, a provider of advanced liver assessment technology, announced a strategic partnership on September 9, 2026, aimed at expanding access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing liver care for patients across the United States. The collaboration seeks to address the significant number of adults living with undiagnosed liver disease by creating a more connected and efficient care pathway.
The partnership combines Aegle Medical’s advanced liver assessment technology solutions, including the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems, with implementation, clinical training, and ongoing customer support. LiverRight contributes its national virtual liver clinic, which provides specialist interpretation and access to hepatology clinicians. Together, they aim to help healthcare organizations move patients efficiently from liver disease identification and non-invasive assessment to specialist interpretation, diagnosis, and longitudinal management.
For physicians, health systems, and independent practices, the partnership is designed to make it easier to establish or expand comprehensive liver disease programs without building every component internally. Aegle Medical offers a consultative approach to technology evaluation, implementation, training, and support, while LiverRight provides same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians. LiverRight’s Liververse™ referral system supports the care pathway by coordinating bloodwork, patient-reported outcomes, available imaging, diagnosis, and longitudinal disease management.
“Aegle Medical Solutions is helping hospital systems and independent practices nationwide address the significant number of adults living with undiagnosed liver disease in the United States,” said Brandon Tudor, CEO of LiverRight. “By working together, we help practices bring advanced liver assessment into the outpatient setting, provide timely specialist interpretation, and move patients into the appropriate diagnostic and care workflow with greater efficiency.”
Michael McTighe, President & CEO of Aegle Medical Solutions, noted that the partnership represents an important step forward in expanding access to liver disease detection and care within communities. “By connecting those capabilities with LiverRight’s nationwide virtual liver-care network and same-day interpretation services, we can provide our customers with more than technology—we can help them establish a more complete pathway from assessment to diagnosis and ongoing patient management,” he said. McTighe added that the model can be particularly valuable for communities where access to hepatology specialists may be limited.
The partnership also highlights the Mindray Hepatus platform, which introduces Visualized Transient Elastography (ViTE), a next-generation breakthrough in transient elastography technology. Unlike conventional platforms that rely primarily on measurement data without real-time anatomical visualization, ViTE integrates real-time B-mode ultrasound visualization directly into the elastography examination. This allows operators to see liver anatomy, identify the optimal measurement location, and visually guide each acquisition while obtaining quantitative liver stiffness and attenuation measurements. The Hepatus platform provides liver stiffness measurement (LSM) for fibrosis assessment and Liver UltraSound Attenuation (LiSA) for quantitative assessment of hepatic steatosis. The Hepatus 6 further expands capabilities with diagnostic ultrasound imaging for abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound.
LiverRight has its own hepatologists and hepatology advanced practice providers licensed across all 50 U.S. states, supporting adult patients with conditions such as MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The strategic relationship gives health systems, GI and hepatology practices, and independent providers a scalable approach to expanding liver services—combining advanced non-invasive liver assessment technology, implementation and clinical support, timely specialist interpretation, and a pathway to continued liver care, all under the provider’s brand. For more information, visit Aegle Medical Solutions and LiverRight.
